32% growth in global generics drives Dr Reddy's top line in Q2

31-10-2013 Business StandardComments (0)

Dr Reddy's LaboratoriesGenerics

Its year-on-year (y-o-y) sales growth of 17 per cent (Rs 3,360 crore) in the second quarter has been largely driven by strong growth in its global generics business. The company's generics business, which grew 32 per cent y-o-y to Rs 2,650 crore ...

Read more on Business Standard

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top